Clinical trial
Vardenafil in Greenlight(TM) Laser Surgery of Benign Prostate Hypertrophy
NCT00461123 · Bayer, Industry · Completed
Key facts
| NCT number | NCT00461123 |
|---|---|
| Title | Vardenafil in Greenlight(TM) Laser Surgery of Benign Prostate Hypertrophy |
| Official title | A Randomized, Double-blind, Parallel Group Prospective Pilot Study to Assess the Effect of Vardenafil on Clinical Outcome and on Procedure Duration After Green Light Laser-ablation of the Prostate Gland for Therapy of Benign Prostate Hypertrophy (BPH) |
| Lead sponsor | Bayer, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostatic Hypertrophy, Benign |
| Intervention type | Drug |
| Interventions | Vardenafil (Levitra, BAY38-9456), Placebo |
| Enrollment | 50 |
| Start date | Mar 1, 2007 |
| Primary completion | Jun 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | Apr 17, 2007 |
| Last update posted | Dec 19, 2014 |
| Countries | Germany |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: